Literature DB >> 32700252

Proteomics-Guided Study on Buyang Huanwu Decoction for Its Neuroprotective and Neurogenic Mechanisms for Transient Ischemic Stroke: Involvements of EGFR/PI3K/Akt/Bad/14-3-3 and Jak2/Stat3/Cyclin D1 Signaling Cascades.

Xi Chen1,2,3, Hansen Chen3, Yachong He3, Shuping Fu3,4, Haosheng Liu1,2, Qi Wang5, Jiangang Shen6,7,8.   

Abstract

Buyang Huanwu Decoction (BHD), a classic traditional Chinese medicine (TCM) formula, has been used for recovering neurological dysfunctions and treating post-stroke disability in China for 200 years. In the present study, we investigated the effects of BHD on inhibiting neuronal apoptosis, promoting proliferation and differentiation of neural stem cells (NSCs) and neurite formation and enhancing learning and memory functional recovery in an experimental rat ischemic stroke model. BHD significantly reduced infarct volume and decreased cell apoptosis in the ischemic brain. BHD enhanced neuronal cell viability in vitro. BHD dose-dependently promoted the proliferation of NSCs in ischemic rat brains in vivo. Moreover, BHD promoted neuronal and astrocyte differentiation in primary cultured NSCs in vitro. Water maze test revealed that BHD promoted the recovery of learning function but not memory functions in the transient ischemic rats. We then investigated the changes of the cellular signaling molecules by using two-dimension (2D) gel electrophoresis and focused on the PI3K/Akt/Bad and Jak2/Stat3/cyclin D1signaling pathway to uncover its underlying mechanisms for its neuroprotective and neurogenetic effects. BHD significantly upregulated the expression of p-PI3K, p-Akt, and p-Bad as well as the expression of p-Jak, p-Stat3, and cyclin D1 in vitro and in vivo. In addition, BHD upregulated Hes1 and downregulated cav-1 in vitro and in vivo. Taken together, these results suggest that BHD has neuroprotective effects and neurogenesis-promoting effects via activating PI3K/Akt/Bad and Jak2/Stat3/Cyclin D1 signaling pathways. Graphical Abstract Buyang Huanwu Decoction (BHD) activates the PI3K-AKT-BAD pathway in the ischemic brain for neuroprotection. BHD also activates JAK2/STAT3/Cyclin D1 signaling cascades for promoting neurogenesis in the hippocampus of post-ischemic brains. Moreover, BHD inhibits the expression of caveolin-1 and increases the expression of HES1 for promoting neuronal differentiation. The neuroprotective and neurogenesis-promoting effects in the hippocampus of post-ischemic brains promote learning ability.

Entities:  

Keywords:  Buyang Huanwu Decoction; Neurogenesis; Neuroprotection; Stroke

Mesh:

Substances:

Year:  2020        PMID: 32700252     DOI: 10.1007/s12035-020-02016-y

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  14 in total

Review 1.  A Review of Traditional Chinese Medicine, Buyang Huanwu Decoction for the Treatment of Cerebral Small Vessel Disease.

Authors:  Liying Sun; Xuhui Ye; Linlin Wang; Junping Yu; Yan Wu; Minpeng Wang; Lihua Dai
Journal:  Front Neurosci       Date:  2022-06-29       Impact factor: 5.152

Review 2.  The PI3K/AKT Pathway-The Potential Key Mechanisms of Traditional Chinese Medicine for Stroke.

Authors:  Chenyang Gu; Qiankun Zhang; Yajing Li; Rong Li; Jia Feng; Wanghao Chen; Waqas Ahmed; Ismatullah Soufiany; Shiying Huang; Jun Long; Lukui Chen
Journal:  Front Med (Lausanne)       Date:  2022-05-31

3.  Naringin Mediates Adult Hippocampal Neurogenesis for Antidepression via Activating CREB Signaling.

Authors:  Chong Gao; Meiling Wu; Qiaohui Du; Jiagang Deng; Jiangang Shen
Journal:  Front Cell Dev Biol       Date:  2022-04-07

4.  Efficacy and safety of Buyang Huanwu-Tang (Boyang Hwano-Tang) in patients with vascular dementia: A protocol of systematic review and meta analysis.

Authors:  Hye Jeong Kook; Da Woon Kim; Ju Yeon Kim; Sang Ho Kim; In Chul Jung
Journal:  Medicine (Baltimore)       Date:  2021-05-28       Impact factor: 1.817

5.  Efficacy and safety of Buyang Huanwu decoction in the treatment of varicose veins of the lower extremities: A protocol of randomized controlled trial.

Authors:  Chuanyong Li; Weijian Fan; Zhichang Pan; Guangfeng Zheng; Qiang Zhang; Jianjie Rong
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.817

6.  Buyang Huanwu Decoction promotes neurogenesis via sirtuin 1/autophagy pathway in a cerebral ischemia model.

Authors:  Han Li; Dong Peng; Shi-Jie Zhang; Yang Zhang; Qi Wang; Li Guan
Journal:  Mol Med Rep       Date:  2021-09-13       Impact factor: 2.952

7.  A Network-Based Approach to Investigate the Neuroprotective Effects and Mechanisms of Action of Huangqi-Chuanxiong and Sanleng-Ezhu Herb Pairs in the Treatment of Cerebral Ischemic Stroke.

Authors:  Lin Zhao; Li Dong Ding; Zi Hao Xia; Peng Sheng; Meng Meng Shen; Zhong Ming Cai; Bing Chun Yan
Journal:  Front Pharmacol       Date:  2022-03-23       Impact factor: 5.810

8.  Neuronal STAT3/HIF-1α/PTRF axis-mediated bioenergetic disturbance exacerbates cerebral ischemia-reperfusion injury via PLA2G4A.

Authors:  Weili Jin; Jixing Zhao; Eryan Yang; Yunfei Wang; Qixue Wang; Ye Wu; Fei Tong; Yanli Tan; Junhu Zhou; Chunsheng Kang
Journal:  Theranostics       Date:  2022-04-04       Impact factor: 11.600

9.  Network pharmacology approach to investigate the multitarget mechanisms of Zhishi Rhubarb Soup on acute cerebral infarction.

Authors:  Yuejia Shao; Yue Zhang; Rongrong Wu; Lurui Dou; Fengjiao Cao; Yuqing Yan; Yuming Tang; Chi Huang; Yang Zhao; Jinghua Zhang
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

10.  Roots of Astragalus propinquus Schischkin Regulate Transmembrane Iron Transport and Ferroptosis to Improve Cerebral Ischemia-Reperfusion Injury.

Authors:  Juan Chen; Donglai Ma; Jun Bao; Ying Zhang; Guoxing Deng
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-02       Impact factor: 2.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.